HomeAXSM • NASDAQ
add
Axsome Therapeutics Inc
Previous close
$150.36
Day range
$147.97 - $152.00
Year range
$75.56 - $152.94
Market cap
7.65B USD
Avg Volume
562.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 170.99M | 63.22% |
Operating expense | 192.00M | 34.68% |
Net income | -47.23M | 26.89% |
Net profit margin | -27.62 | 55.21% |
Earnings per share | -0.94 | 29.85% |
EBITDA | -31.20M | 29.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 325.27M | -0.63% |
Total assets | 669.25M | 19.20% |
Total liabilities | 595.52M | 27.10% |
Total equity | 73.73M | — |
Shares outstanding | 50.41M | — |
Price to book | 102.29 | — |
Return on assets | -12.58% | — |
Return on capital | -28.25% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -47.23M | 26.89% |
Cash from operations | 1.05M | 105.61% |
Cash from investing | -58.00K | 35.56% |
Cash from financing | 21.27M | -30.05% |
Net change in cash | 22.26M | 90.48% |
Free cash flow | 13.77M | 528.99% |
About
Founded
2012
Website
Employees
816
